- Home
- GGAL vs CYTK Comparison
GGAL vs CYTK Comparison
Compare GGAL & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGAL
- CYTK
- Stock Information
- Founded
- GGAL 1905
- CYTK 1997
- Country
- GGAL Argentina
- CYTK United States
- Employees
- GGAL N/A
- CYTK N/A
- Industry
- GGAL Commercial Banks
- CYTK Biotechnology: Pharmaceutical Preparations
- Sector
- GGAL Finance
- CYTK Health Care
- Exchange
- GGAL Nasdaq
- CYTK Nasdaq
- Market Cap
- GGAL 10.0B
- CYTK 5.6B
- IPO Year
- GGAL N/A
- CYTK 2004
- Fundamental
- Price
- GGAL $58.05
- CYTK $31.02
- Analyst Decision
- GGAL Strong Buy
- CYTK Buy
- Analyst Count
- GGAL 4
- CYTK 15
- Target Price
- GGAL $59.00
- CYTK $73.71
- AVG Volume (30 Days)
- GGAL 1.2M
- CYTK 2.4M
- Earning Date
- GGAL 01-01-0001
- CYTK 05-06-2025
- Dividend Yield
- GGAL 2.83%
- CYTK N/A
- EPS Growth
- GGAL 120.03
- CYTK N/A
- EPS
- GGAL 1.06
- CYTK N/A
- Revenue
- GGAL $6,697,505,438.00
- CYTK $19,218,000.00
- Revenue This Year
- GGAL $11.73
- CYTK $24.01
- Revenue Next Year
- GGAL N/A
- CYTK $698.33
- P/E Ratio
- GGAL $5.91
- CYTK N/A
- Revenue Growth
- GGAL N/A
- CYTK 412.21
- 52 Week Low
- GGAL $23.53
- CYTK $29.31
- 52 Week High
- GGAL $74.00
- CYTK $61.38
- Technical
- Relative Strength Index (RSI)
- GGAL 42.16
- CYTK 39.05
- Support Level
- GGAL $56.73
- CYTK $30.02
- Resistance Level
- GGAL $61.47
- CYTK $31.27
- Average True Range (ATR)
- GGAL 2.65
- CYTK 1.40
- MACD
- GGAL -0.56
- CYTK 0.24
- Stochastic Oscillator
- GGAL 15.89
- CYTK 42.12
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.